相关实验视频
Updated: Jan 14, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.5K
在小鼠模型中,Kcnn4/KCa3.1 抑制会抑制多囊性病的进展
Guanhan Yao1, Almira Kurbegovic1, Camila Parrot1
1Molecular Genetics and Development, Institut de recherches cliniques de Montréal, Montréal, Québec, Canada.
JCI insight
|October 22, 2025
概括
用senicapoc准KCa3.1通道可能会减缓自身主导多囊性病 (ADPKD) 的进展. 这项研究表明,抑制KCa3.1可以减少囊生长,改善功能,并在PKD模型中延长存活时间.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自体主导多囊性病 (ADPKD) 中囊生长的机制尚未完全理解.
- 表皮盐和水分泌,涉及K+循环,驱动囊扩张.
- 编码为KCNN4的K+通道KCa3.1是一个潜在的治疗目标.
研究的目的:
- 调查KCNN4/KCa3.1在ADPKD病变发生中的作用.
- 评估基因和药理学KCa3.1抑制在减缓PKD进展方面的有效性.
主要方法:
- 在人类ADPKD脏和小鼠模型中分析KCNN4表达.
- 在实验室研究中,使用与KCa3.1激动剂/对抗剂的小鼠甲基尼.
- 在体内研究使用Pkd1小鼠模型与Kcnn4无活化或senicapoc治疗.
主要成果:
- 在ADPKD脏和PKD小鼠模型中,KCNN4被上调.
- 激活KCa3.1刺激了囊的扩张; senicapoc阻止/逆转了它.
- 在Pkd1模型中,Kcnn4无活化和senicapoc治疗减缓了囊生长,减少了纤维化,改善了功能,并延长了存活时间.
- 与PKD相关的信号通路,状腺延长和细胞增殖被减弱.
结论:
- KCa3.1通道活动显著促进ADPKD细胞形成.
- 抑制KCa3.1,特别是使用senicapoc,证明了ADPKD的治疗潜力.
- 建议Senicapoc作为ADPKD治疗的临床试验候选者.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
335
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
335
01:25Chronic Kidney Disease I: Introduction
557
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
557
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
257
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
257